Soluble CD30 antigen in human colostrum
A Bertotto1, C Vagliasindi, R Gerli
1Department of Paediatrics, Perugia University School Medicine, Italy.
Biology of the Neonate
|January 1, 1997
Summary
High levels of soluble CD30 (sCD30) were detected in colostrum, suggesting CD30+ T cells play a role in mammary gland immunity during lactation. This finding offers insights into immune support for newborns via breast milk.
Area of Science:
- Immunology
- Cell Biology
- Human Physiology
Background:
- CD30 is a surface antigen on activated T cells, historically linked to T-helper 2 (Th2) cytokine production.
- Emerging evidence indicates CD30 expression is broader, also found on activated T cells with Th1 and Th0 cytokine profiles.
- Activated T cells expressing CD30 release a soluble form, sCD30, detectable in vitro and in vivo.
Purpose of the Study:
- To investigate the presence and levels of soluble CD30 (sCD30) in human colostrum.
- To explore the potential role of CD30+ T cells in the immunological processes of the mammary gland during pregnancy and lactation.
Main Methods:
- Quantification of sCD30 levels in colostrum samples from puerperal women.
- Comparison of sCD30 levels in colostrum with matched blood samples from the same women.
- Analysis of sCD30 levels in blood samples from non-pregnant women as a control.
Main Results:
- Significantly elevated levels of sCD30 were detected in colostrum samples from 20 puerperal women.
- sCD30 was not detected in the autologous blood samples of these women.
- sCD30 was also absent in blood samples from heterologous non-pregnant women.
Conclusions:
- The high concentration of sCD30 in colostrum strongly suggests the involvement of CD30+ T cells in mammary gland immunity.
- These findings support a role for CD30+ T cells in providing immunological benefits to newborns through breast milk.
- Further research is needed to elucidate the specific mechanisms by which T cells contribute to the immunological support of newborns.
